After months of procedural wrangling and negotiations about settlement, the asbestos plaintiff’s bar has now attacked the Bestwall/Georgia-Pacific chapter 11 as a “bad faith” filing. The motion is online.

The motion sets out a broad attack. Among other things, the motion focuses attention on GP’s one-day use of a Texas statute to divide up

As reported by Laurie Kazan Allen at the IBAS web site and in other places, a new fund has been created in Switzerland to pay compensation to persons suffering from asbestos-related diseases. The Swiss Info channel reported the news in a December 19, 2016 online article. The following are excerpts from the article:


Researchers continue to generate more and more data and hypotheses regarding mesothelioma in persons with a germline (inherited) BAP1 mutation. The newest paper went online yesterday, from Carbone, Pass and Yang, among others. The abstract states:


Germline BAP1 mutations predispose to several cancers, in particular malignant mesothelioma. Mesothelioma is an aggressive malignancy generally associated

There are many double-edged swords in mass tort litigation. Some people see them, and some do not, too often because of a propensity for consuming kool-aid as instructed by others. Sometimes the double-edged swords are mentioned in public, and other times, not so much. It’s refreshing to read David Christian’s comments on double-edged swords in

Due to a Second Circuit ruling yesterday, Travelers is about out of rope in its effort to avoid paying $500 million to asbestos plaintiffs who sued it directly for its role in suppressing information about the full extent of the health hazards of asbestos. The suits arose because Travelers was Manville’s primary insurer while

Most insurers, defendants and various interested others can and should be spending money to find additional causes of mesothelioma. The vast majority, however, are not. Therefore, it is somewhat serendipitous that researchers from NIEHS at Triangle Park recently may have found another substance that appears to promote the development of mesothelioma. The work arises from

Messrs. Cohn, Shelley and Arnold are back with a valuable new article:  The Need for Further Transparency Between the Tort System and Section 524(g) Asbestos trusts, 2014 Update – Judicial and Legislative Developments and Other Changes in the Landscape Since 2008, Widener Law Journal (2014). The paper is a valuable follow up to their

A June 13, 2014  paper by Dr. Joseph Testa and colleagues expands the ongoing investigation into the relationships among mesothelioma, asbestos fibers, pleural and peritoneal exposures, and the BAP1 mutation (both germline and somatic mutations are under investigation). The research involves creation of a line of “knockout” mice with the BAP1 mutation, and then monitoring